- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Acute T-lymphoblastic Leukemia in United States
Total 2752 results
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationCompletedMyelomonocytic LeukemiaUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
Astex Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States, Canada, Spain, Hungary, Austria, Czechia, France, Germany, Italy, United Kingdom
-
St. Jude Children's Research HospitalOhio State University; Arog Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Vion PharmaceuticalsCompletedLeukemiaFrance, Canada, Greece, United States, Belgium, Netherlands, United Kingdom, Germany, Poland, Serbia
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma | Lymphoblastic Leukemia | Hodgkin's Disease | Myelogenous LeukemiaUnited States
-
Forma Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Eric Stephen Winer, MDRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2United States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
CelgeneTerminatedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, France, Canada, Norway, Spain, United Kingdom
-
Aptose Biosciences Inc.Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Ohio State University Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.; Celgene CorporationCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | LeukemiaUnited States
-
Ryvu Therapeutics SAActive, not recruitingAcute Myeloid Leukemia | High-risk Myelodysplastic SyndromeUnited States, Poland
-
Becton, Dickinson and CompanyRecruitingAcute LeukemiaUnited States, Spain, Brazil, Czechia, United Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, New Zealand, Puerto Rico
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsTerminatedLeukemia, Myelocytic, AcuteUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedRefractory Acute Myeloid Leukemia | Myelodysplastic Syndrome RAEB-I or RAEB-II | Refractory CML Myeloid Blast CrisisUnited States
-
Medical Research CouncilCompletedMyelodysplastic Syndromes | LeukemiaUnited Kingdom
-
Janssen Research & Development, LLCCompletedLeukemia, Myeloid, AcuteUnited States, Australia, France, Poland, Taiwan, Belgium, Germany, United Kingdom, Spain, Israel, Turkey, Korea, Republic of, Russian Federation, Sweden
-
University of UtahGenzyme, a Sanofi CompanyTerminatedCancer | Chronic Myelomonocytic LeukemiaUnited States
-
University of BirminghamActive, not recruitingAcute Myeloid Leukemia | MyelodysplasiaUnited Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Australia, Canada
-
Rush University Medical CenterNational Cancer Institute (NCI)UnknownMyelodysplastic Syndromes | Leukemia | Neutropenia | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Brigham and Women's HospitalCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingOsteosarcoma | Lymphoblastic Lymphoma | Recurrent Lymphoma | Recurrent Malignant Neoplasm | Hodgkin Lymphoma in Remission | Leukemia in Remission | Recurrent LeukemiaUnited States, Australia, Canada, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Novartis PharmaceuticalsActive, not recruitingLeukemiaUnited States, Canada
-
CelgeneRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Australia, Spain, Canada, United Kingdom
-
Riverside Haematology GroupUnknownMyelodysplastic Syndromes | LeukemiaUnited Kingdom
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Previously Treated Myelodysplastic Syndromes | Refractory Anemia With Excess Blasts | Refractory Anemia With Excess Blasts in TransformationUnited States
-
NextCure, Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Chronic Myelomonocytic Leukemia | Relapsed or Refractory Myelodysplastic SyndromeUnited States
-
Masonic Cancer Center, University of MinnesotaRecruiting
-
Celyad Oncology SANational Heart, Lung, and Blood Institute (NHLBI); Dana-Farber Cancer InstituteCompletedAcute Myeloid Leukemia | Multiple Myeloma | Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)RecruitingSarcoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Neurofibroma, Plexiform | Leukemia, Promyelocytic, AcuteUnited States
-
Weill Medical College of Cornell UniversityNew York Blood CenterTerminatedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
NexImmune Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States
-
Astex Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmUnited States, Canada
-
Seagen Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Brigham and Women's HospitalCompletedMyelofibrosis | Chronic Myelomonocytic Leukemia | Myeloid Metaplasia | Agnogenic Myeloid MetaplasiaUnited States
-
Dana-Farber Cancer InstituteThe Leukemia and Lymphoma SocietyEnrolling by invitationAcute Myeloid Leukemia | Myelodysplastic Syndromes | Juvenile Myelomonocytic Leukemia | Myeloproliferative NeoplasmUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Vor BiopharmaRecruitingLeukemia, Myeloid, AcuteUnited States
-
PfizerCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States, United Kingdom, Belgium, Canada, Germany, France
-
University of Alabama at BirminghamRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States
-
GT Biopharma, Inc.TerminatedAcute Myelogenous Leukemia | Systemic Mastocytosis | Mast Cell Leukemia | High-risk Myelodysplastic SyndromesUnited States
-
Massachusetts General HospitalRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States